Cat.#: ACPP-1650
| Despition | HSPB8 Human Recombinant |
| SIZE | 2 µg |
| Purity | > 95.0% (SDS-PAGE) |
| Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1273 | BTB/POZ domain-containing protein 7 Blocking Peptide (AC1273) | 250 µg | inquiry |
| ACPP-1709 | Human GPC4 Protein (AC1709) | 2 µg | inquiry |
| ACPP-1754 | Human VEGFC Protein, Sf9 (AC1754) | 2 µg | inquiry |
| ACPP-1669 | Human NRGN Protein (AC1669) | 2 µg | inquiry |
| ACPP-1636 | Vasopressin (AC1636) | 5 mg | inquiry |
| ACPP-1761 | Human VCAM1 Protein (AC1761) | 2 µg | inquiry |
| ACPP-1419 | Human TAC3 Protein (AC1419) | 5 µg | inquiry |
| ACPP-1826 | Human CRYGN Protein (AC1826) | 5 µg | inquiry |
| ACPP-1600 | Mouse IL 6 Protein, Sf9 (AC1600) | 2 µg | inquiry |
| ACPP-1004 | Synthetic Nanodisc Human GPCR GPR20 Protein (AC1004) | 10 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.